Multi-omic search for early biomarkers in CMT1A
Official title: A Multi-omic Approach to the Identification of Novel Biomarkers in Early Charcot-Marie-Tooth 1A Disease (CMT1A) (CMT-MODs)
Run by University Medical Center Goettingen · NCT07476365 · Data updated 2026-11-12
This project will test whether blood-based molecular signatures and qMRI measures in children and young adults with CMT1A can predict how the disease will progress.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 10 Years to 30 Years |
| Sex | All |
| Enrollment | 70 (estimated) |
| Sponsor | University Medical Center Goettingen Academic / other |
| Locations | 1 site (Göttingen) |
| Status | Recruiting |
| Started | March 24, 2025 |
| Main results expected | June 30, 2026 |
| Study ends | September 30, 2026 |
| Registry record updated | April 13, 2026 |
| Trial ID | NCT07476365 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are cooperative patients aged 10–30 with a genetic diagnosis of CMT1A (or clinical diagnosis plus an affected relative) who are able to walk with or without support.
✕Probably not a fit
Patients with other neuromuscular disorders, contraindications to qMRI, or those outside the 10–30 age range may not be eligible or likely to benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational project collects blood samples and quantitative MRI from children, adolescents, and young adults (age 10–30) with genetically confirmed or family-diagnosed CMT1A. Researchers will perform transcriptomics and other multi-omic analyses on blood and correlate those signals with MRI biomarkers and clinical measures. Biomarker candidates will be informed by prior findings in CMT1A rat models and adult patient samples to build predictive models of future disease course. The aim is to find easily obtainable prognostic markers usable before peripheral nerves undergo advanced degeneration.
Why it matters
Potential benefit: If successful, this work could allow earlier identification of patients at higher risk of progression, enabling timely interventions and more personalized care planning.
How similar studies have gone: Preclinical data from CMT1A rats and gene-expression correlations in adult CMT1A patients support this multi-omic approach, but applying it in young patients is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion criteria: * collaborative children, adolescents and young adults aged 10-30 years * genetic diagnosis of CMT1A, or clinical diagnosis and genetic diagnosis in affected relatives * able to walk with/ without support. Exclusion Criteria: * neuromuscular disorders other than CMT1A * concomitant disease preventing correct patient evaluation and contraindication to qMRI
Where it's running
-
University Medical Centre
Göttingen, Germany Recruiting
Study contacts
- Principal investigator: Michael W Sereda — University Medical Centre Göttingen
- Study coordinator: Michael W Sereda, Prof. of Neurology
- Email: sereda@mpinat.mpg.de
- Phone: +49 551 3964162
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Understanding biomarkers and outcomes in Charcot-Marie-Tooth disease
This study is trying to see how Charcot-Marie-Tooth disease type 1A changes over time by looking at blood and skin samples from patients and healthy people to find better ways to track the disease and develop new treatments.
-
Autonomic problems in Charcot–Marie–Tooth disease
This study will test how common and how severe autonomic (automatic nervous system) symptoms are in adults aged 18–65 with genetically confirmed Charcot–Marie–Tooth disease compared with healthy volunteers.
-
Tremor in Charcot–Marie–Tooth disease
Try to characterize tremor in adults with Charcot–Marie–Tooth (CMT) disease using surface electromyography, accelerometers, a clinical exam and questionnaires to see how tremor affects daily life.
-
Nerve function and structure in CMT, anti‑MAG neuropathy, and CIDP
This project will test nerve‑conduction, axonal‑excitability, skin biopsy, and ultrasound measures in adults with CMT, CIDP, or anti‑MAG neuropathy to see if they better describe nerve function and structure.
-
Collecting data and samples from patients with leukodystrophy
This study is collecting health information and samples from people with leukodystrophy to help find new causes and better treatments for the condition.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.